Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
ACELRX PHARMA (NQ: ACRX)
7.860 USD  +0.410 (+5.50%)
Official Closing Price  /  Updated: 8:10 PM EDT, May 24, 2013  /  Add to My Watchlist      
View: Quote News
All news about ACELRX PHARMA
 
< Previous 1 2 3 4 5 Next >
Bio-Wire Equity Surveillance – Closing Bell 5/22/2013
May 22, 2013
Notable Jumps by % Gain / Mkt Cap Change MannKind Corporation (NASDAQ: MNKD) +16.2 after Piper Jaffray analyst Ian Somaiya estimates a potential valuation of the company in the $3-4B range in the event... Read More
category Bio/Wire
from Bio-Wire.Com
Canaccord Boosts PT on AcelRx (ACRX) to $11; On Track for Sufentanil NDA Submission by Q313
May 22, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8361424 for the full story. Read More
from StreetInsider.com News Articles
AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX), NPS Pharmaceuticals, Inc. (NASDAQ:NPSP) and Cubist Pharmaceuticals Inc. (NASDAQ:CBST) Added to Growing Stock Report's NASDAQ Active Stock Watch List.
May 22, 2013
New York, NY -- (SBWIRE) -- 05/22/2013 -- Growing Stock Report expands its NASDAQ Active Stock Watch List adding AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX), NPS Pharmaceuticals, Inc. (NASDAQ:NPSP) and... Read More
from SBWire - Latest Press Releases
Free Research Reports on ACRX, SHLD, TJX and XEL Issued by the Paragon Report
May 22, 2013
Note to Editors: The Following Is an Investment Opinion Being Issued by the EQUITY NEWS CIRCUIT Read More
from Marketwired News Releases
Market Wrap: Sprint Ponies Up for Clearwire; Herbalife Engages Auditor; 'One' for Microsoft
May 21, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8359916 for the full story. Read More
from StreetInsider.com News Articles
AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX), NPS Pharmaceuticals, Inc. (NASDAQ:NPSP), and Cubist Pharmaceuticals Inc. (NASDAQ:CBST) Added to Equity Profile Report's NASDAQ Gainers Watch List.
May 21, 2013
Wilmington, DE -- (SBWIRE) -- 05/21/2013 -- Equity Profile Report expands its NASDAQ Gainers Weekly Watch List adding AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX), NPS Pharmaceuticals, Inc.... Read More
from SBWire - Latest Press Releases
AcelRx Pharmaceuticals (ACRX) gains on positive test results
May 21, 2013
AcelRx Pharmaceuticals (NASDAQ: ACRX) soared 5.3% to $6.80 after the company announced positive results from Phase 3 study of Sufentanil NanoTab PCA system. Share volume was 178,000, nearly triple its... Read More
from BAYSTREET RSS FEED
StreetInsider.com Pre-Open Movers 5/21: (YGE) (SDBT) (ACRX) Higher; (HGG) (CCL) (BBY) Lower (more...)
May 21, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8357784 for the full story. Read More
from StreetInsider.com News Articles
AcelRx Pharma (ACRX) Stock Higher; Sufentanil NanoTab Study Meets Primary Endpoint
May 21, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8356947 for the full story. Read More
from StreetInsider.com News Articles
Top-line Data Demonstrate Primary Endpoint Achieved in Final Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Management of Post-Operative Pain
May 21, 2013
- Following major orthopedic surgery, Sufentanil NanoTab-treated patients experienced significantly greater reduction in pain as measured by SPID-48 vs. placebo (p<0.001) - Read More
from PR Newswire
AcelRx Pharmaceuticals to Present at the UBS Global Healthcare Conference
May 16, 2013
from PR Newswire
AcelRx Pharmaceuticals Reports First Quarter 2013 Financial Results
May 08, 2013
from PR Newswire
AcelRx Pharmaceuticals to Hold First Quarter 2013 Financial Results Conference Call and Webcast on May 8, 2013
May 03, 2013
from PR Newswire
AcelRx Pharmaceuticals Presents Positive Clinical Data for the Sufentanil NanoTab PCA System at ASRA Medical Meeting
May 02, 2013
- Additional Phase 3 analysis show significantly faster reduction in pain and fewer patients with oxygen desaturation events for Sufentanil NanoTab PCA System than IV PCA with morphine - Read More
from PR Newswire
Top-line Data Show AcelRx Pharmaceuticals' ARX-04 Achieves Primary Endpoint in Dose-Finding Phase 2 Clinical Trial
April 24, 2013
- Patients in the 30 mcg sufentanil NanoTab treatment group experienced significantly greater reduction in pain as measured by SPID-12 vs. placebo - Read More
from PR Newswire
NASDAQ Decliners Watch List: ChemoCentryx, Inc. (NASDAQ:CCXI), AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX), Keynote Systems, Inc. (NASDAQ:KEYN), and Pure Cycle Corporation (NASDAQ:PCYO) Added to Growin
April 17, 2013
New York, NY -- (SBWIRE) -- 04/17/2013 -- Growing Stock Report expands its NASDAQ Decliners Weekly Watch List adding ChemoCentryx, Inc. (NASDAQ:CCXI), AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX),... Read More
from SBWire - Latest Press Releases
AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) and OncoGenex Pharmaceuticals, Inc. (NASDAQ:OGXI) Added to Growing Stock Report's NASDAQ Gainers Watch List.
April 11, 2013
New York, NY -- (SBWIRE) -- 04/11/2013 -- Growing Stock Report expands its NASDAQ Gainers Weekly Watch List adding AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) and OncoGenex Pharmaceuticals, Inc.... Read More
from SBWire - Latest Press Releases
UPDATE: Jefferies Initiates AcelRx Pharmaceuticals with Buy on Expected FDA Approval for ARX-01
April 08, 2013
In a report published Monday, Jefferies analyst Corey Davis initiated coverage on AcelRx Pharmaceuticals (NASDAQ: ACRX ) with a Buy rating and $8.00 price target. In the report, Davis noted, “We expect... Read More
category Benzinga , ACRX , Initiation , and 3 more.
from Latest Articles from Benzinga.com
Benzinga's Top Initiations
April 08, 2013
Analysts at Jefferies initiated coverage on shares of AcelRx Pharmaceuticals (NASDAQ: ACRX ) with a “buy” rating. The target price range for AcelRx Pharmaceuticals is set to $8.00. AcelRx... Read More
category Benzinga , HPTX , ACRX , and 5 more.
from Latest Articles from Benzinga.com
Jefferies Starts AcelRx Pharmaceuticals (ACRX) at Buy
April 08, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8237842 for the full story. Read More
from StreetInsider.com News Articles
NASDAQ Stocks Closed Higher: CombiMatrix Corporation, AcelRx Pharmaceuticals Inc, magicJack VocalTec Ltd, Consumer Portfolio Services
March 25, 2013
Lakeway, TX -- (SBWIRE) -- 03/25/2013 -- Bestdamnpennystocks, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the... Read More
from SBWire - Latest Press Releases
AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) and the Madison Square Garden Company (NASDAQ:MSG) Added to Growing Stock Report's NASDAQ Gainers Watch List.
March 22, 2013
New York, NY -- (SBWIRE) -- 03/22/2013 -- Growing Stock Report expands its NASDAQ Gainers Weekly Watch List adding AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) and The Madison Square Garden Company... Read More
from SBWire - Latest Press Releases
Significant Catalysts And Company PR Error Present Significant Opportunity In AcelRx Pharmaceuticals
March 20, 2013
category Pharmaceuticals
from Trefis
AcelRx Pharmaceuticals (ACRX) Posts Q4 Loss of 41c/Share
March 12, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8178803 for the full story. Read More
from StreetInsider.com News Articles
AcelRx Pharmaceuticals Reports Fourth Quarter and Full-Year 2012 Financial Results
March 12, 2013
from PR Newswire
Market Preview - Bringing Things Into Perspective
March 12, 2013
category Market/Outlook , Wall/Street/Preview , Market/Outlook/2013/Q1
from Wall Street Greek
Week Ahead – Detailed Economic & Corporate Schedule
March 11, 2013
category Market/Outlook , Week/Ahead , Market/Outlook/2013/Q1
from Wall Street Greek
CombiMatrix Corporation (NASDAQ:CBMX), James River Coal Co. (NASDAQ:JRCC), and AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) Added to Growing Stock Report's NASDAQ Decliners Watch List.
March 08, 2013
New York, NY -- (SBWIRE) -- 03/08/2013 -- Growing Stock Report expands its NASDAQ Decliners Weekly Watch List adding CombiMatrix Corporation (NASDAQ:CBMX), James River Coal Co. (NASDAQ:JRCC), and... Read More
from SBWire - Latest Press Releases
AcelRx Pharmaceuticals to Hold Fourth Quarter 2012 Financial Results Conference Call and Webcast on March 12, 2013
March 07, 2013
from PR Newswire
Ascena Retail Group Inc. (NASDAQ:ASNA) and AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) Added to Growing Stock Report's NASDAQ Watch List
March 05, 2013
New York, NY -- (SBWIRE) -- 03/05/2013 -- Growing Stock Report expands its NASDAQ Watch List adding Ascena Retail Group Inc. (NASDAQ:ASNA) and AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) Read More
from SBWire - Latest Press Releases
< Previous 1 2 3 4 5 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here